Jorge Rouvier

816 total citations
24 papers, 604 citations indexed

About

Jorge Rouvier is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jorge Rouvier has authored 24 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 8 papers in Internal Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jorge Rouvier's work include Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Jorge Rouvier is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Jorge Rouvier collaborates with scholars based in Argentina, United States and Switzerland. Jorge Rouvier's co-authors include Raúl Altman, Luis de la Fuente, Enrique Gurfinkel, René G. Favaloro, R. Favaloro, Fernando Boullón, Claudio González, Alexander G.G. Turpie, Jawed Fareed and M Verstraete and has published in prestigious journals such as Circulation, The American Journal of Medicine and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Jorge Rouvier

23 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Rouvier Argentina 13 403 204 132 111 102 24 604
Martina Brückmann Germany 4 105 0.3× 49 0.2× 106 0.8× 438 3.9× 83 0.8× 5 641
Rosemarie Reiter Austria 10 151 0.4× 72 0.4× 75 0.6× 114 1.0× 39 0.4× 13 522
Hannelore Haubelt Germany 14 200 0.5× 94 0.5× 101 0.8× 28 0.3× 84 0.8× 22 747
Jayesh Jani United States 9 144 0.4× 245 1.2× 125 0.9× 68 0.6× 44 0.4× 15 491
D Loew Germany 10 187 0.5× 67 0.3× 139 1.1× 111 1.0× 66 0.6× 16 467
L H Kahlé Netherlands 12 56 0.1× 33 0.2× 55 0.4× 50 0.5× 76 0.7× 22 361
Wojciech Sydor Poland 8 119 0.3× 100 0.5× 122 0.9× 62 0.6× 85 0.8× 25 433
R Konopka United States 12 190 0.5× 167 0.8× 122 0.9× 68 0.6× 330 3.2× 25 566
Philippe Close Switzerland 12 556 1.4× 640 3.1× 502 3.8× 28 0.3× 37 0.4× 19 914
Green Rm United States 10 159 0.4× 41 0.2× 388 2.9× 94 0.8× 244 2.4× 20 680

Countries citing papers authored by Jorge Rouvier

Since Specialization
Citations

This map shows the geographic impact of Jorge Rouvier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Rouvier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Rouvier more than expected).

Fields of papers citing papers by Jorge Rouvier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Rouvier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Rouvier. The network helps show where Jorge Rouvier may publish in the future.

Co-authorship network of co-authors of Jorge Rouvier

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Rouvier. A scholar is included among the top collaborators of Jorge Rouvier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Rouvier. Jorge Rouvier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dejean, C., M. Bosset, Y. Pointreau, et al.. (2021). A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients. Cancer/Radiothérapie. 25(8). 755–762. 5 indexed citations
2.
Sun, Roger, Jorge Rouvier, Olivier Mauvais, et al.. (2020). Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases. Cancer/Radiothérapie. 24(8). 812–819. 7 indexed citations
3.
Altman, Raúl, et al.. (2002). No Causal Association Between Inflammation and Chlamydia Pneumoniae in Patients with Chronic Ischemic Arterial Disease. Inflammation. 26(1). 25–30. 5 indexed citations
4.
Altman, Raúl, Jorge Rouvier, Claudio González, et al.. (2000). Abciximab treatment in vitro after aspirin treatment in vivo has additive effects on platelet aggregation, ATP release, and P-selectin expression. Thrombosis Research. 100(6). 479–488. 10 indexed citations
5.
Rouvier, Jorge, et al.. (2000). Effect of Sodium Arachidonate on Thrombin Generation through Platelet Activation – Inhibitory Effect of Aspirin. Thrombosis and Haemostasis. 84(12). 1109–1112. 13 indexed citations
6.
Altman, Raúl, et al.. (1999). Lack of association between prior infection with chlamydia pneumoniaeand acute or chronic coronary artery disease. Clinical Cardiology. 22(2). 85–90. 33 indexed citations
7.
Altman, Raúl, et al.. (1999). Effects of Ticlopidine or Ticlopidine Plus Aspirin on Platelet Aggregation and ATP Release in Normal Volunteers: Why Aspirin Improves Ticlopidine Antiplatelet Activity. Clinical and Applied Thrombosis/Hemostasis. 5(4). 243–246. 12 indexed citations
8.
Altman, Raúl, et al.. (1998). Efficacy of Unfractionated Heparin, Low Molecular Weight Heparin and Both Combined for Releasing Total and Free Tissue Factor Pathway Inhibitor. Pathophysiology of Haemostasis and Thrombosis. 28(5). 229–235. 16 indexed citations
9.
Altman, Raúl, et al.. (1996). Coagulation and fibrinolytic parameters in patients with pulmonary hypertension. Clinical Cardiology. 19(7). 549–554. 38 indexed citations
10.
Rouvier, Jorge, et al.. (1996). Comparison of High-Dose With Low-Dose Aspirin in Patients With Mechanical Heart Valve Replacement Treated With Oral Anticoagulant. Circulation. 94(9). 2113–2116. 39 indexed citations
11.
Altman, Raúl, Jorge Rouvier, & Enrique Gurfinkel. (1995). Oral Anticoagulant Treatment with and without Aspirin. Thrombosis and Haemostasis. 74(1). 506–510. 15 indexed citations
12.
13.
Altman, Raúl, Jorge Rouvier, & Enrique Gurfinkel. (1991). Invited letter concerning: Anticoagulant plus platelet inhibitor therapy in patients with mechanical valve prostheses: Reply to the Editor. Journal of Thoracic and Cardiovascular Surgery. 101(3). 559–559. 2 indexed citations
14.
Altman, Raúl, et al.. (1991). Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. Journal of Thoracic and Cardiovascular Surgery. 101(3). 427–431. 168 indexed citations
15.
Altman, Raúl, et al.. (1986). Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 1.Studies in normal human platelet rich plasma. Thrombosis Research. 43(1). 103–111. 6 indexed citations
16.
Altman, Raúl, Jorge Rouvier, & H Weisenberger. (1985). Identification of Platelet Inhibitor Present in the Melon (Cucurbitacea Cucumis Melo). Thrombosis and Haemostasis. 53(3). 312–313. 16 indexed citations
17.
Altman, Raúl, et al.. (1976). Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. Journal of Thoracic and Cardiovascular Surgery. 72(1). 127–129. 133 indexed citations
18.
Collen, Désiré, Jorge Rouvier, & Marc Verstraete. (1972). Metabolism of iodine labeled plasminogen and prothrombin in cirrhosis of the liver. Clinical research. 20. 483. 5 indexed citations
19.
Altman, Raúl, et al.. (1969). Unusual complications in the course of anticoagulant therapy. The American Journal of Medicine. 46(3). 460–463. 27 indexed citations
20.
Altman, Russ B., et al.. (1966). Combined Factor VIII and IX Inhibitors in a Girl. Thrombosis and Haemostasis. 16(03/04). 549–558. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina Brückmann Breakdown of academic impact, for papers by Rosemarie Reiter Breakdown of academic impact, for papers by Hannelore Haubelt Breakdown of academic impact, for papers by Jayesh Jani Breakdown of academic impact, for papers by D Loew Breakdown of academic impact, for papers by L H Kahlé Breakdown of academic impact, for papers by Wojciech Sydor Breakdown of academic impact, for papers by R Konopka Breakdown of academic impact, for papers by Philippe Close Breakdown of academic impact, for papers by Green Rm
Rankless by CCL
2026